ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health disparities and population studies"

  • Abstract Number: 2063 • 2019 ACR/ARP Annual Meeting

    Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)

    Martin A Rodriguez1, Jaspreet K Sodhi 1 and Soham Al Snih 1, 1The University of Texas Medical Branch, Galveston

    Background/Purpose: To examine the effect of arthritis on upper-lower extremity (UE-LE) functional limitations and disability over 6-years of follow-up among American older adults.Methods: Data are…
  • Abstract Number: 278 • 2018 ACR/ARHP Annual Meeting

    The Effect of Patient, Prescriber and Region on the Initiation of First Biologic for Rheumatoid Arthritis: A Longitudinal Population Study

    Mark Tatangelo1, George A. Tomlinson2, Michael Paterson3, Nick Bansback4, Tara Gomes1, Alex Kopp3, Vandana Ahluwalia5 and Claire Bombardier6, 1University of Toronto, Toronto, ON, Canada, 2Medicine, Mount Sinai Hospital, Toronto, ON, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 4St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, 5Ontario Rheumatology Association, Brampton, ON, Canada, 6Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Prescribing the first biologic for rheumatoid arthritis is an important decision for physicians, payers, and patients with costs and clinical implications. Our aim was…
  • Abstract Number: 154 • 2013 ACR/ARHP Annual Meeting

    Identification Of Autoimmune Disease Genes In Regions Under Selection In The Gullah African American Population Of South Carolina

    Paula S. Ramos1, Nathan Titus2, Satria Sajuthi3, Jasmin Divers3, Yiqi Huang4, Uma Nayak5, Wei-Min Chen5, Kelly J. Hunt6, Diane L. Kamen7, Gary S. Gilkeson7, Jyotika K. Fernandes8, Ida J. Spruill8, W. Timothy Garvey9, Michèle M. Sale4 and Carl D. Langefeld3, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 5Public Health Sciences, University of Virginia, Charlottesville, VA, 6Public Health Sciences, Medical University of South Carolina, Charleston, SC, 7Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 8Medical University of South Carolina, Charleston, SC, 9Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Most autoimmune diseases (ADs) are more prevalent in specific ethnic groups. We hypothesize that one reason for the ethnic disparity may be an effect…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology